Cargando…
History of the Rare Cancer Network and Past Research
Approximately, twenty years ago, the Rare Cancer Network (RCN) was formed in Lausanne, Switzerland, to support the study of rare malignancies. The RCN has grown over the years and now includes 130 investigators from twenty-four nations on six continents. The network held its first international symp...
Autores principales: | Mirimanoff, René-Olivier, Ozsahin, Mahmut, Thariat, Juliette, Ozyar, Enis, Schick, Ulrike, Pehlivan, Berrin, Krengli, Marco, Pellanda, Alessandra Franzetti, Vees, Hansjörg, Cai, Ling, Scandolaro, Luciano, Belkacemi, Yazid, Villà, Salvador, Igdem, Sefik, Lutsyk, Myroslav, Miller, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178278/ https://www.ncbi.nlm.nih.gov/pubmed/25276325 http://dx.doi.org/10.4081/rt.2014.5462 |
Ejemplares similares
-
The Rare Cancer Network: Ongoing Studies and Future Strategy
por: Ozsahin, Mahmut, et al.
Publicado: (2014) -
Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study
por: Zwahlen, Daniel R., et al.
Publicado: (2016) -
Primary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study
por: Ugurluer, Gamze, et al.
Publicado: (2016) -
Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study
por: Jeanneret-Sozzi, Wendy, et al.
Publicado: (2008) -
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series
por: De Bari, Berardino, et al.
Publicado: (2019)